Table 1 The association between SEMA4B expression and clinicopathological variables
Characteristic | Low expression of SEMA4B | High expression of SEMA4B | p |
|---|---|---|---|
n | 267 | 268 | Â |
T stage, n (%) | Â | Â | 0.004 |
 T1 | 104 (19.5%) | 71 (13.3%) |  |
 T2 | 137 (25.8%) | 152 (28.6%) |  |
 T3 | 16 (3%) | 33 (6.2%) |  |
 T4 | 8 (1.5%) | 11 (2.1%) |  |
N stage, n (%) | Â | Â | < 0.001 |
 N0 | 193 (37.2%) | 155 (29.9%) |  |
 N1 | 36 (6.9%) | 59 (11.4%) |  |
 N2 | 27 (5.2%) | 47 (9.1%) |  |
 N3 | 0 (0%) | 2 (0.4%) |  |
M stage, n (%) | Â | Â | 0.759 |
 M0 | 178 (46.1%) | 183 (47.4%) |  |
 M1 | 11 (2.8%) | 14 (3.6%) |  |
Pathologic stage, n (%) | Â | Â | < 0.001 |
 Stage I | 172 (32.6%) | 122 (23.1%) |  |
 Stage II | 47 (8.9%) | 76 (14.4%) |  |
 Stage III | 31 (5.9%) | 53 (10.1%) |  |
 Stage IV | 12 (2.3%) | 14 (2.7%) |  |
Gender, n (%) | Â | Â | 0.006 |
 Female | 159 (29.7%) | 127 (23.7%) |  |
 Male | 108 (20.2%) | 141 (26.4%) |  |
Race, n (%) | Â | Â | 0.937 |
 Asian | 4 (0.9%) | 3 (0.6%) |  |
 Black or African American | 27 (5.8%) | 28 (6%) |  |
 White | 209 (44.7%) | 197 (42.1%) |  |
Age, n (%) | Â | Â | 0.427 |
 <=65 | 122 (23.6%) | 133 (25.8%) |  |
 > 65 | 135 (26.2%) | 126 (24.4%) |  |
Smoker, n (%) | Â | Â | 1.000 |
 No | 37 (7.1%) | 38 (7.3%) |  |
 Yes | 221 (42.4%) | 225 (43.2%) |  |
OS event, n (%) | Â | Â | 0.016 |
 Alive | 185 (34.6%) | 158 (29.5%) |  |
 Dead | 82 (15.3%) | 110 (20.6%) |  |
PFI event, n (%) | Â | Â | 0.765 |
 Alive | 152 (28.4%) | 157 (29.3%) |  |
 Dead | 115 (21.5%) | 111 (20.7%) |  |
Age, meidan (IQR) | 67 (60, 72) | 65 (57, 72) | 0.136 |